nerve-sparing RP. Patient factors, cancer selection, type of surgery, surgical techniques, and surgeon factors represent the key significant contributors to erectile function recovery. The aim of a penile rehabilitation program is to preserve the functional smooth-muscle content of the corpus cavernosum during the neuropraxia period. Phosphodiesterase type 5 (PDE5) inhibitors are commonly used in rehabilitation programs. In animal models, such an approach could promote erectile function recovery, improve smooth muscle-to-collagen penile ration, reduce penile apoptotic index, preserve penile endothelial function and promote neuroprotection during nerve damage. Despite the strong basic science support from animal studies, discordant results have been reached in humans. The previous randomized trials comparing chronic versus on-demand PDE-5 inhibitors use after RP may be affected by improper patients' selection in that only men at low risk of postoperative ED were included. These patients would recover erectile function regardless of the type of PDE5 inhibitor administration because of their excellent baseline profile. Prospective, randomized trials have shown a significant benefit of daily PDE5-I administration as compared with placebo in terms of postoperative EF recovery. Patients with intermediate risk of ED after surgery are the best candidates for daily treatment with PDE5 inhibitor after bilateral nerve-sparing RP. The maximal effect of penile rehabilitation may be found in those men with a certain (but not high) degree of systemic and erectile impairment preoperatively. In conclusion, penile rehabilitation could achieve faster and better natural erectile function after RP and should be started as early as possible. Chronic use of PDE5-I may confer the maximal gain as compared to the on-demand administration schedule. Attention should be pained to the observation that rehabilitation protocols are beneficial even in men with spontaneous erections postoperatively because further improvement in such patients was reported. severe oligozoospermic men mainly is azoospermia factor (AZF) region, include AZFa, AZFb, AZFbc, AZFc and AZFabc, only the microdeletions of relevant region have the specific clinical manifestation; (II) the guideline think the supposed AZFd region by some experts and recommended by some commercial diagnostic kits does not exist. The gr/gr deletion in AZFc region is a genetic risk factor for sperm production, but the clinical implications is not confirmed, not be recommended as the routine detection item; (III) the guideline still recommended the classical 6 sits detection, excessively high number of markers do not improve the sensitivity of the test, may even complicate the interpretation of the results, the method based on two multiplex polymerase chain reactions remains fully valid and appropriate for accurate diagnosis of AZF deletions; (IV) the performance of 12 years EQA scheme indicate that participating laboratories has demonstrated an improvement on reporting practice and decreasing diagnostic error rates by improve the performance. In Chinese infertility men, the frequency of Y chromosomal microdeletions occurrence is in high level, as 11.5%. We suggest the AZF diagnostic should be the routine detection item for azoospermic and severe oligozoospermic men, call on domestic AZF detection laboratory join the EQA scheme and complete the performance of Y chromosome microdeletions detection.
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